Drug-eluting stents

Bifurcations

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary...

Dr. Andrés Rodríguez - 31 March, 2025

Chronic Coronary Syndromes

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and...

Dr. Omar Tupayachi - 25 March, 2025

Chronic Ischemic cardiopathy

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

Coronary angioplasty with drug-eluting stents (DES) is associated with a 2-3% annual incidence of stent-related events, a...

Dr. Andrés Rodríguez - 5 March, 2025

Acute coronary syndromes

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option...

Dr. Omar Tupayachi - 21 January, 2025

Coronary disease

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation...

Dr. Carlos Fava - 5 November, 2024

Coronary disease

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to...

Dr. Andrés Rodríguez - 30 October, 2024

Coronary disease

Paclitaxel-Eluting vs. Sirolimus-Eluting Balloons

Coronary restenosis remains one of the main challenges in percutaneous transluminal coronary angioplasty (PTCA), especially nowadays, when...

Dr. Carlos Fava - 28 October, 2024

Acute coronary syndromes

Results of the PROSPECT II Substudy: Relationship Between In-Stent or Stent Edge-Related Lipid-Rich Plaque and Adverse Clinical Events After PCI in Patients with MI

The use of drug-eluting stents and the integration of intravascular imaging techniques have reduced the risk of...

Dr. Andrés Rodríguez - 21 October, 2024

Drug-eluting stents

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

Early and Late Outcomes with the ABSORB Bioresorbable Scaffold

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Evolution of Small Balloon-Expandable Valves

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

Paclitaxel-Eluting vs. Sirolimus-Eluting Balloons

Results of the PROSPECT II Substudy: Relationship Between In-Stent or Stent Edge-Related Lipid-Rich Plaque and Adverse Clinical Events After PCI in Patients with MI

Últimas Noticias

TAVR in Small Annuli: What Valve Should We Use?

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Noticias Institucionales

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Watch our event on Evidence and Controversies of Renal Denervation in 2025

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

Accesos